Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL873204 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL32678404 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL14841540 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL8738678 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL19718040 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL18138230 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL24534431 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL19718041 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL17836881 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL1773862 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4637702-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | Coty Inc. (US) | 2025-10-29 | — | — | EP | claimed |
| WO-2024137340-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | COTY INC. (US) | 2024-06-27 | — | — | WO | claimed |
| EP-1894603-B1 | Encapsulation of bulky fragrance molecules | TAKASAGO PERFUMERY CO LTD (JP) | 2014-11-19 | — | — | EP | claimed |
| WO-2026046686-A1 | EVAPORATING MICROEMULSIONS | SYMRISE AG (DE) | 2026-03-05 | — | — | WO | disclosed |
| WO-2026046506-A1 | EVAPORATING MICROEMULSIONS | SYMRISE AG (DE) | 2026-03-05 | — | — | WO | disclosed |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2026-02-19 | — | — | US | disclosed |
| US-20260027132-A1 | FRAGRANCE COMPOSITIONS AND USE THEREOF FOR IMPROVING SLEEP | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2026-01-29 | — | — | US | disclosed |
| EP-4486290-B1 | FIXATIVE MOLECULES | SYMRISE AG (DE) | 2025-12-03 | — | — | EP | disclosed |
| EP-4637702-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | Coty Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-4637702-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | Coty Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| US-12453736-B2 | Fragrance compositions and use thereof for improving sleep | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2025-10-28 | — | — | US | disclosed |
| US-20160206522-A1 | MICROCAPSULES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-07-21 | — | — | US | disclosed |
| CN-105431225-A | Microcapsule | TAKASAGO PERFUMERY CO LTD | 2016-03-23 | — | — | CN | disclosed |
| WO-2015016369-A1 | MICROCAPSULES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-02-05 | — | — | WO | disclosed |
| EP-2832441-A1 | Microcapsules | Takasago International Corporation (JP) | 2015-02-04 | — | — | EP | disclosed |
| EP-1894603-B1 | Encapsulation of bulky fragrance molecules | TAKASAGO PERFUMERY CO LTD (JP) | 2014-11-19 | — | — | EP | disclosed |
| US-8609600-B2 | Encapsulation of bulky fragrance molecules | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-12-17 | — | — | US | disclosed |
| US-20100248390-A1 | COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS | DUKE UNIVERSITY (US) | 2010-09-30 | — | — | US | disclosed |
| US-20080176780-A1 | ENCAPSULATION OF BULKY FRAGRANCE MOLECULES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-07-24 | — | — | US | disclosed |
| EP-1894603-A1 | Encapsulation of bulky fragrance molecules | Takasago International Corporation (JP) | 2008-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027132-A1 | FRAGRANCE COMPOSITIONS AND USE THEREOF FOR IMPROVING SLEEP | B2M, PER2, CHRM2 | ALOX15 633/4885ALDH1A1 132/4885LMNA 761/4885 |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | RBP4, LRAT, RARB | ALOX15 438/4885ALDH1A1 156/4885LMNA 2563/4885 |
| US-20160206522-A1 | MICROCAPSULES | MITF, PLIN5, MLEC | ALOX15 64/4885ALDH1A1 3127/4885LMNA 753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.